Venkata-Rangarao Kanikanti

USPTO Granted Patents = 15 (Patent Applications = 9)

CIPO Patents = 6 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 10)

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 120(Granted Patents)

Company Filing History:

4 out of 12,157

Bayer Aktiengesellschaft

patents

4 out of 54

Bayer Animal Health Gmbh

patents

3 out of 192

Bayer Schering Pharma Ag

patents

4. 2 out of 721

Bayer Intellectual Property Gmbh

Bayer Pharma Aktiengesellschaft

patents

Years Active: 1998-2022

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11382865 - Pharmaceutical preparation and method for its manufacture (2022-07-12),

2. 11147764 - Tablets with improved acceptance and good storage stability (2021-10-19),

3. 10543170 - Tablets with improved acceptance and good storage stability (2020-01-28),

4. 10251932 - Preparations containing amorphous emodepside (2019-04-09),

5. 9744127 - Non-starch based soft chewables (2017-08-29),

6. 9539331 - Preparations containing amorphous emodepside (2017-01-10),

7. 8187632 - Sustained-release preparations of quinolone antibiotics (2012-05-29),

8. 7858120 - Pharmaceutical formulations containing flavouring substances with improved pharmaceutical properties (2010-12-28),

9. 7780986 - Method of preparing sustained-release preparations of quinolone antibiotics (2010-08-24),

10. 7763583 - Endoparasiticidal compositions for topical application (2010-07-27),

11. 7709022 - Sustained-release preparations of quinolone antibiotics and method for preparation thereof (2010-05-04),

12. 6805881 - Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same (2004-10-19),

13. 6569455 - Quick-release extrudates, method for preparing the same and compositions obtained from said extrudates (2003-05-27),

14. 5900425 - Pharmaceutical preparations having controlled release of active compound (1999-05-04),

15. 5707655 - Process for the preparation of medicament formulations with controlled (1998-01-13),

Title: Venkata-Rangarao Kanikanti: Innovator in Pharmaceutical Preparations

Introduction

Venkata-Rangarao Kanikanti is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of 15 patents. His work focuses on developing innovative pharmaceutical preparations that enhance the effectiveness and stability of medications.

Latest Patents

One of his latest patents involves a pharmaceutical preparation that includes a first composition with a matrix material and active ingredients such as Praziquantel, Pyrantel, and Febantel. This preparation also features a second composition containing avermectins and milbemycins, like Moxidectin, structured in a multi-layer format. The first and second layers are separated by a barrier layer, ensuring optimal delivery of the active ingredients. Another significant patent pertains to tablets designed for animals, which boast improved acceptance and good storage stability.

Career Highlights

Throughout his career, Venkata-Rangarao Kanikanti has worked with prominent companies in the pharmaceutical industry, including Bayer Aktiengesellschaft and Bayer Animal Health GmbH. His expertise in pharmaceutical formulations has led to advancements that benefit both human and animal health.

Collaborations

He has collaborated with esteemed colleagues such as Hans-Juergen Hamann and Roland Rupp, contributing to the development of innovative solutions in the pharmaceutical sector.

Conclusion

Venkata-Rangarao Kanikanti's contributions to pharmaceutical innovations demonstrate his commitment to improving medication efficacy and stability. His patents reflect a deep understanding of pharmaceutical science and a dedication to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.